Meta-Analysis Assesses Targeted Therapies for MET-Altered Non-Small Cell Lung Cancer
A systematic review and meta-analysis of 25 clinical trials found that MET tyrosine kinase inhibitors achieved a 49 percent objective response rate in MET-altered non-small cell lu...